$CRSP #Stocks #StockMarket #CrisprTherapeuticsAg issued Q1 EPS on https://t.co/savSNTKlN1: CRSP reported disastrous Q1, where Sales faded by -52.134 % to $0.157 MM and loss per share has widen to $-1.15, from the same quarter a year ago. https://t.co/oPkCNFpY0F